Quantum-Si aims to revolutionize protein sequencing amidst technological hurdles, uncertain advancements, and market ...

Quantum-Si's next-gen protein sequencing tech and growth partnerships show promise, but high costs, financial risks, and ...

Quantum-Si (NasdaqGM:QSI) recently announced its participation in the upcoming AGBT meeting, highlighting its advancements in Next-Generation Protein Sequencing, alongside establishing a Scientific ...

Quantum-Si (NASDAQ:QSI – Get Free Report) is expected to be announcing its earnings results after the market closes on Monday ...

Reports Q4 revenue $1.2M, consensus $1.2M. “I am very pleased with how we closed out 2024, delivering our first quarter in excess of $1 million ...

Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that the Compensation Committee of Quantum-Si’s Board ...

Quantum-Si Inc (QSI) reports a 183% annual revenue increase and strategic milestones, despite challenges in market penetration and funding uncertainties.

Quantum-Si, the pioneer in Next-Generation Protein ... on revolutionizing the growing field of proteomics. The Company’s Platinum ® line of instruments enables Next-Gen Protein Sequencing ...

Pre-earnings options volume in Quantum Si is normal with calls leading puts 5:2. Implied volatility suggests the market is anticipating a move ...

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company ™, today ...